Sei Investments Co. Purchases 9,192 Shares of Perrigo Company (PRGO)

Sei Investments Co. lifted its position in Perrigo Company (NYSE:PRGO) by 7.5% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 131,284 shares of the company’s stock after buying an additional 9,192 shares during the quarter. Sei Investments Co. owned about 0.09% of Perrigo worth $11,114,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Allen Investment Management LLC boosted its position in Perrigo by 7.1% during the second quarter. Allen Investment Management LLC now owns 7,143 shares of the company’s stock worth $539,000 after purchasing an additional 473 shares during the period. State Street Corp boosted its position in Perrigo by 1.7% during the second quarter. State Street Corp now owns 6,757,086 shares of the company’s stock worth $510,294,000 after purchasing an additional 112,287 shares during the period. Monetta Financial Services Inc. bought a new stake in Perrigo during the second quarter worth approximately $755,000. Andra AP fonden boosted its position in Perrigo by 9.9% during the third quarter. Andra AP fonden now owns 16,700 shares of the company’s stock worth $1,414,000 after purchasing an additional 1,500 shares during the period. Finally, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp boosted its position in Perrigo by 32.5% during the second quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 54,530 shares of the company’s stock worth $4,118,000 after purchasing an additional 13,382 shares during the period. 80.98% of the stock is owned by institutional investors and hedge funds.

In other Perrigo news, EVP Jeffrey Needham sold 3,595 shares of the stock in a transaction on Tuesday, September 12th. The stock was sold at an average price of $89.49, for a total transaction of $321,716.55. Following the completion of the transaction, the executive vice president now directly owns 10,118 shares in the company, valued at $905,459.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Thomas Farrington sold 616 shares of the stock in a transaction on Wednesday, August 30th. The stock was sold at an average price of $76.90, for a total value of $47,370.40. Following the transaction, the executive vice president now owns 2,724 shares of the company’s stock, valued at $209,475.60. The disclosure for this sale can be found here. Insiders sold 6,029 shares of company stock valued at $513,504 over the last 90 days. 6.90% of the stock is currently owned by corporate insiders.

Perrigo Company (NYSE PRGO) opened at $85.89 on Monday. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.72 and a quick ratio of 1.24. The company has a market capitalization of $12,096.81, a price-to-earnings ratio of 17.53, a P/E/G ratio of 1.83 and a beta of 0.69. Perrigo Company has a 12 month low of $63.68 and a 12 month high of $91.73.

Perrigo (NYSE:PRGO) last issued its earnings results on Thursday, November 9th. The company reported $1.39 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.28. The business had revenue of $1.22 billion during the quarter, compared to analyst estimates of $1.17 billion. Perrigo had a positive return on equity of 11.60% and a negative net margin of 26.28%. Perrigo’s revenue was down 2.0% on a year-over-year basis. During the same period in the prior year, the company posted $1.65 earnings per share. research analysts predict that Perrigo Company will post 4.88 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 19th. Investors of record on Friday, December 1st will be paid a $0.16 dividend. The ex-dividend date of this dividend is Thursday, November 30th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.75%. Perrigo’s payout ratio is -6.99%.

A number of equities research analysts have issued reports on PRGO shares. Goldman Sachs Group, Inc. (The) raised Perrigo from a “sell” rating to a “neutral” rating and upped their target price for the stock from $66.00 to $79.00 in a research report on Friday, August 11th. Jefferies Group LLC set a $71.00 target price on Perrigo and gave the stock a “hold” rating in a research report on Sunday, October 29th. UBS AG reaffirmed a “buy” rating and set a $98.00 target price (up previously from $84.00) on shares of Perrigo in a research report on Thursday, October 5th. Oppenheimer Holdings, Inc. started coverage on Perrigo in a research report on Thursday, September 7th. They set an “outperform” rating and a $88.00 target price for the company. Finally, Cantor Fitzgerald upped their price target on Perrigo from $93.00 to $107.00 and gave the stock an “overweight” rating in a report on Tuesday, September 12th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and eight have given a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of $91.50.

COPYRIGHT VIOLATION NOTICE: “Sei Investments Co. Purchases 9,192 Shares of Perrigo Company (PRGO)” was published by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this story on another website, it was illegally stolen and republished in violation of US & international copyright and trademark law. The correct version of this story can be read at https://stocknewstimes.com/2017/11/20/sei-investments-co-purchases-9192-shares-of-perrigo-company-prgo.html.

Perrigo Company Profile

Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.

Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company (NYSE:PRGO).

Institutional Ownership by Quarter for Perrigo (NYSE:PRGO)

Receive News & Ratings for Perrigo Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply